Origin, Clinical Presentation, and Diagnosis of Hypomelanotic Skin Disorders

Dermatologic Clinics

Volumn 25, Issue 3, 2007, Pages 363-371

  Mollet, Ilse ^a   Ongenae, Katia ^a   Naeyaert, Jean Marie ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CORTICOSTEROID; HYDROQUINONE; IMMUNOSUPPRESSIVE AGENT; MONOBENZONE;

CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; ERYTHEMA STREPTOGENES; HALO NEVUS; HUMAN; HYPOMELANOSIS; IDIOPATHIC GUTTATE HYPOMELANOSIS; LEUKODERMA PUNCTATA; LICHEN SCLEROSUS ET ATROPHICUS; LUPUS ERYTHEMATOSUS; MELANOMA ASSOCIATED LEUKODERMA; MELANOSIS; PITYRIASIS; PRIORITY JOURNAL; REVIEW; SCLERODERMA; TINEA VERSICOLOR; VITILIGO;

ALGORITHMS; HUMANS; HYPOPIGMENTATION; LICHEN SCLEROSUS ET ATROPHICUS; MELANOMA; NEVUS, PIGMENTED; PITYRIASIS; SKIN NEOPLASMS; TINEA VERSICOLOR; VITILIGO;

EID: 34447622274     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2007.04.013     Document Type: Review

References (55)

1. Mosher D.B., Fitzpatrick T.B., Ortonne J.P., et al. Normal skin color and general considerations of pigmentary disorders. In: Freedberg I.M., Eisen A.Z., Wolff K., et al. (Eds). Fitzpatrick's dermatology in general medicine. 5th edition (1999), McGraw-Hill, New York 936-944
2. Asawanonda P., and Taylor C.R. Wood's light in dermatology. Int J Dermatol 38 (1999) 801-807
3. Paraskevas L.R., Halpern A.C., and Marghoob A.A. Utility of the wood's light: five cases from a pigmented lesion clinic. Br J Dermatol 152 (2005) 1039-1044
4. Thoma W., Krämer H.J., and Maysert P. Pityriasis versicolor alba. J Eur Acad Dermatol Venerol 19 (2005) 147-152
5. Crespo-Erchiga V., and Florencio V.D. Malassezia yeasts and pityriasis versicolor. Curr Opin Infect Dis 19 (2006) 139-147
6. Gupta A.K., Batra R., Bluhm R., et al. Skin diseases associated with Malassezia species. J Am Acad Dermatol 51 (2004) 785-798
7. Farnsworth N., and Rosen T. Endemic treponematosis: review and update. Clin Dermatol 24 3 (2006) 181-190
8. Enk C.D. Onchocerciasis: river blindness. Clin Dermatol 24 3 (2006) 176-180
9. Ramos-e-Silva M., and Rebello P.F. Leprosy: recognition and treatment. Am J Clin Dermatol 2 4 (2001) 203-211
10. Blessmann Weber M., Sponchiado de Ávilla L.G., Albaneze R., et al. Pityriasis alba: a study of pathogenic factors. J Eur Acad Dermatol Venerol 16 (2002) 463-468
11. Lin R.L., and Janniger C.K. Pityriasis alba. Cutis 76 1 (2005) 21-24
12. Lerner E.A., and Sober A.J. Chemical and pharmacologic agents that cause hyperpigmentation or hypopigmentation of the skin. Dermatol Clin 6 2 (1988) 327-337
13. Lacour J.P. Physical agents causing hypomelanoses. In: Nordlund J.J., Boissy R.E., Hearing V.J., et al. (Eds). The pigmentary system: physiology and pathophysiology. 2nd edition (2006), Blackwell Publishing Ltd., Oxford (UK) 683-685
14. Kuhn A., Gensch K., Stander S., et al. Cutaneous lupus erythematosus. Part 1. Clinical manipulations and classification. Hautarzt 57 (2006) 251-268 [in German]
15. Bonifati C., Impara G., Morrone A., et al. Simultaneous occurrence of linear scleroderma and homolateral segmental vitiligo. J Eur Acad Dermatol Venerol 20 (2006) 63-65
16. Ee H.L., and Tan S.H. Reticulate hyperpigmented scleroderma: a new pigmentary manifestation. Clin Exp Dermatol 30 (2005) 131-133
17. Meffert J.J., Davis B.M., and Grimwood R.E. Lichen sclerosus. J Am Acad Dermatol 32 3 (1995) 393-416
18. Funaro D. Lichen sclerosus: a review and practical approach. Dermatol Ther 17 (2004) 28-37
19. Val I., and Almeida G. An overview of lichen sclerosus. Clin Obstet Gynecol 48 4 (2005) 808-817
20. Carlson J.A., Grabowski R., Mu X.C., et al. Possible mechanisms of hypopigmentation in lichen sclerosus. Am J Dermatopathol 24 2 (2002) 97-107
21. Carlson J.A., Lamb P., Malfetano J., et al. Clinicopathologic comparison of vulvar and extragenital lichen sclerosus: histologic variants, evolving lesions, and etiology of 141 cases. Mod Pathol 11 9 (1998) 844-854
22. Njoo M.D., and Westerhof W. Vitiligo: pathogenesis and treatment. Am J Clin Dermatol 2 (2001) 167-181
23. Hann S.K., and Nordlund J.J. Clinical features of generalized vitiligo. In: Hann S.K., and Nordlund J.J. (Eds). Vitiligo: a monograph on the basic and clinical science (2000), Blackwell Science, Oxford (UK) 35-48
24. Ortonne J.P., Mosher D.B., and Fitzpatrick T.B. Vitiligo. In: Ortonne J.P., Mosher D.B., and Fitzpatrick T.B. (Eds). Vitiligo and other hypomelanoses of hair and skin (1983), Plenum Publishing Corporation, New York 129-310
25. Kovacs S.O. Vitiligo. J Am Acad Dermatol 38 (1998) 647-666
26. Ortonne J.P. Special features of vitiligo. In: Hann S.K., and Nordlund J.J. (Eds). Vitiligo: a monograph on the basic and clinical science (2000), Blackwell Science, Oxford (UK) 70-75
27. Hann S.K. Clinical features of segmental vitiligo. In: Hann S.K., and Nordlund J.J. (Eds). Vitiligo: a monograph on the basic and clinical science (2000), Blackwell Science, Oxford (UK) 49-60
28. Le Poole I.C., van den Wijngaard R.M., Westerhof W., et al. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol 148 (1996) 1219-1228
29. Boissy E.B. Histology of vitiliginous skin. In: Hann S.K., and Nordlund J.J. (Eds). Vitiligo: a monograph on the basic and clinical science (2000), Blackwell Science, Oxford (UK) 23-34
30. Ongenae K., van Geel N., and Naeyaert J.M. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res 16 (2003) 90-100
31. Gauthier Y., Cario Andre M., and Taïeb A. A critical appraisal of vitiligo etiologic theories: is melanocyte loss a melanocytorrhagy?. Pigment Cell Res 16 (2003) 322-332
32. Castenet J., and Ortonne J.P. Pathophysiology of vitiligo. Clin Dermatol 15 (1997) 845-851
33. Le Poole I.C., Das P.K., van den Wijngaard R.M., et al. Review of ethiopathomechanism of vitiligo: a convergence theory. Exp Dermatol 2 (1993) 145-153
34. Gauthier Y., Cario Andre M., Lepreux S., et al. Melanocyte detachment after skin friction in nonlesional skin of patients with generalized vitiligo. Br J Dermatol 148 (2003) 95-101
35. Ortonne J.P., Mosher D.B., and Fitzpatrick T.B. Leukoderma acquisitum centrifugum: halo nevus and other hypomelanoses associated with neoplasms. In: Ortonne J.P., Mosher D.B., and Fitzpatrick T.B. (Eds). Vitiligo and other hypomelanoses of hair and skin (1983), Plenum Publishing Corporation, New York 567-611
36. Frank S.B., and Cohen H.U. The halo nevus. Arch Dermatol 89 (1964) 367-371
37. Akasu R., From L., and Kahn H.J. Characterization of the mononuclear infiltrate involved in regression of halo nevi. J Cutan Pathol 21 (1994) 302-311
38. th edition (2005), Lippincott Williams and Wilkins, Philadelphia 715-803
39. Zeff R.A., Freitag A., Grin C.M., et al. The immune response in halo nevi. J Am Acad Dermatol 37 (1997) 620-624
40. Musette P., Bachelez H., Flageul B., et al. Immune-mediated destruction of melanocytes in halo nevi is associated with the local expansion of a limited number of T cell clones. J Immunol 162 (1999) 1789-1794
41. Barona M.I., Arrunategui A., Falabella R., et al. An epidemiologic case-control study in a population with vitiligo. J Am Acad Dermatol 36 (1997) 282-283
42. de Vijlder H.C., Westerhof W., Schreuder G.M., et al. Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study. Pigment Cell Res 17 (2004) 270-274
43. nd edition (2006), Blackwell Publishing Ltd., Oxford (UK) 705-724
44. Rodriguez-Cuevas S., Lopez-Chavira A., Zepeda del Rio G., et al. Prognostic significance of cutaneous depigmentation in Mexican patients with malignant melanoma. Arch Med Res 29 2 (1998) 155-158
45. Yee C., Thompson J.A., Roche P., et al. Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of T cell-mediated vitiligo. J Exp Med 192 11 (2000) 1637-1643
46. Rosenberg S.A., Yang J.C., Schwartzentruber D.J., et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med 4 3 (1998) 321-327
47. Becker J.C., Guldberg P., Zeuthen J., et al. Accumulation of identical T cells in melanoma and vitiligo-like leukoderma. J Invest Dermatol 113 (1999) 1033-1038
48. Wallace M.L., Grichnik J.M., Prieto V.G., et al. Numbers and differentiation status of melanocytes in idiopathic guttate hypomelanosis. J Cutan Pathol 25 (1998) 375-379
49. Falabella R., Escobar C.E., Carrascal E., et al. Leukoderma punctata. J Am Acad Dermatol 18 3 (1988) 485-494
50. Park Y.K., Hann S.K., Hong K.T., et al. Generalized punctate leukoderma following UVB phototherapy in the psoriasis patients. Annals of Dermatology 2 (1990) 93-95
51. Park J.H., and Lee M.H. Case of leukoderma punctata after topical PUVA treatment. Int J Dermatol 43 2 (2004) 138-139
52. Westerhof W., Relyveld G.N., Kingswijk M.M., et al. Propionibacterium acnes and the pathogenesis of progressive macular hypomelanosis. Arch Dermatol 140 (2004) 210-214
53. Gülekon A., Özsoy E., Gürer M.A., et al. Hypopigmented mycosis fungoides in an adolescent Turkish boy. Int J Dermatol 44 (2005) 795-796
54. Mashek H., and Kalb R. Hypopigmentation of the extremities. Arch Dermatol 134 (1998) 743-748
55. Konkolova R. Acquired hypomelanoses. In: Lotti T., and Hercogová J. (Eds). Vitiligo problems and solutions (2004), Marcel Dekker Inc., New York 381-388